Rechallenge and maintenance therapy using cetuximab and chemotherapy administered to a patient with metastatic colorectal cancer

Overview of attention for article published in BMC Cancer, February 2017

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 6 Dimensions

Readers on

mendeley: 26 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 6 publications that cite this research output.

6

The most recent citing publications are shown below. View all 6 publications that cite this research output on Dimensions.

CAFs-secreted exosomal cricN4BP2L2 promoted colorectal cancer stemness and chemoresistance by interacting with EIF4A3

Article in Experimental Cell Research (June 2022)

Lobaplatin hyperthermic intraperitoneal chemotherapy plus cytoreduction and rechallenge using cetuximab for wild-type RAS peritoneal metastatic colon cancer: a case report and literature review

Article in BMC Gastroenterology (February 2022)

De-escalation of the systemic therapy in advanced colorectal cancer – justified clinical practice from the point of view of efficiency and safety

Article in Nowotwory Journal of Oncology (October 2021)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.